What does my Follicular Lymphoma biomarker profile mean for treatment options

Follicular LymphomaMay 22, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Your Follicular Lymphoma Biomarker Profile

I'd be happy to help you understand what biomarkers mean for your treatment. However, I notice you haven't shared your specific biomarker results yet. Could you upload your pathology report or lab results? That way, I can explain what YOUR particular findings mean.

In the meantime, let me explain how biomarkers work in follicular lymphoma so you understand what to look for:

How Biomarkers Guide Treatment Decisions

According to the NCCN Guidelines for Follicular Lymphoma, biomarker testing is a key part of understanding your cancer and choosing the best treatment approach. Here's what doctors are looking for:

Common Biomarkers in Follicular Lymphoma

Protein markers (found on cancer cell surfaces):

  • CD10, BCL2, CD20, BCL6 - These help confirm the diagnosis of follicular lymphoma
  • Ki-67 - This measures how fast cells are dividing (higher numbers = faster growth)
  • IRF4/MUM1 - This can affect treatment decisions

Gene mutations (changes in the DNA of cancer cells):

  • BCL6, EZH2, IRF4/MUM1 - These mutations can be targeted with specific therapies
  • Chromosome translocations - Detected through tests like FISH (fluorescence in situ hybridization) or karyotype

Blood tumor markers:

  • Beta-2-microglobulin (B2M) - A protein in your blood that helps doctors assess disease burden and prognosis

Why This Matters for Treatment

According to NCCN Guidelines, certain mutations "may determine the type of treatment given." For example:

  • Some mutations respond better to targeted therapies
  • Others may indicate resistance to certain drugs
  • Your biomarker profile helps your doctor choose between options like rituximab (a CD20-targeting antibody), newer targeted drugs, or chemotherapy combinations

What I Need From You

Please share:

  • Your pathology report (biopsy results)
  • Any genetic testing results
  • Lab values, especially B2M if available
  • Your disease stage (I, II, III, or IV)

Once you upload these, I can explain:

  • What each finding means in plain language
  • How these results typically influence treatment decisions
  • Specific questions to ask your oncologist about YOUR situation

Questions to Ask Your Care Team Now

While you're gathering your results, consider asking:

  1. What biomarkers were tested on my biopsy, and what did they show?
  2. Do any of my biomarkers indicate I'm a candidate for targeted therapy?
  3. How do my specific biomarkers affect which treatment options you're recommending?
  4. Are there any mutations that might affect how well certain treatments work?
  5. Will you retest my biomarkers if my cancer comes back or stops responding to treatment?

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: